Product Images Sildenafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Sildenafil NDC 43063-668 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

43063668 Label - 43063668

43063668 Label - 43063668

This is a package of Sildenafil tablets containing 20mg each, with 30 tablets in total. The tablets have Teva 5517 and Fj|M coated Sildenafil Citrate USP printed on them. The medication is to be taken a certain number of times per day, but the dosing information is only available in the package insert. The packaging includes an expiration date of 01/2050 and the lot number is SAMPLE. Along with typical warnings about keeping this medication out of reach of children, there is also an instruction in Spanish to take the tablet(s) a certain number of times a day. Additionally, there is a note to contact a doctor regarding possible side effects and also a warning to the FDA to report these side effects, along with contact information for the FDA.*

Figure 6: Kaplan-Meier Plot of Mortality by Sildenafil Dose - image 01

Figure 6: Kaplan-Meier Plot of Mortality by Sildenafil Dose - image 01

sildenafil citrate structural formula - image 02

sildenafil citrate structural formula - image 02

Figure 9. Change From Baseline in 6 Minute Walk Distance (Meters) at Weeks 4, 8, and 12 in Study 1: Mean (95% Confidence Interval) - image 05

Figure 9. Change From Baseline in 6 Minute Walk Distance (Meters) at Weeks 4, 8, and 12 in Study 1: Mean (95% Confidence Interval) - image 05

Figure 10. Placebo-Corrected Change From Baseline in 6 Minute Walk Distance (Meters) at Week 12 by Study Subpopulation in Study 1: Mean (95% Confidence Interval) - image 06

Figure 10. Placebo-Corrected Change From Baseline in 6 Minute Walk Distance (Meters) at Week 12 by Study Subpopulation in Study 1: Mean (95% Confidence Interval) - image 06

Figure 11. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in Study 2 - image 07

Figure 11. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in Study 2 - image 07

Figure 12. Mean Change from Baseline in Six Minute Walk (meters) by Visit to Week 12 – ITT Population Sildenafil Protocol A1481244 - image 08

Figure 12. Mean Change from Baseline in Six Minute Walk (meters) by Visit to Week 12 – ITT Population Sildenafil Protocol A1481244 - image 08

The plot shows the change from baseline in meters for each treatment at each visit up to week 12, with the mean value and standard error indicated for each. The text appears to be related to a study of the effects of different doses of sildenafil.*

sildenafil f7new

sildenafil f7new

This is a chart that presents different drugs (Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, Saquinavirt) along with other parameters such as AuC, Cmax and their Fold Change and 90% CI Recommendations. The chart informs the reader if a dose adjustment is needed or not in the presence of sildenafil.*

sildenafil f8new

sildenafil f8new

This is a drug interaction chart indicating the effects of various drugs on Acenocoumarol. The chart mentions how the level of INR AUC, INR Cmax, Auc, and Cmax change depending on the interaction with the other drugs. The chart also mentions if any dose adjustment is recommended or not. There is also a note on the effect of sildenafil on exercise capacity when added to bosentan therapy. Lastly, there is mention of the effect of ritonavir on sildenafil PK.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.